OrthoPediatrics Corp. Launches DF2 Brace®
OrthoPediatrics Corp., a leading company dedicated to advancing pediatric orthopedics, has just announced the limited release of their groundbreaking DF2® Brace. This innovative brace marks a significant milestone in the non-surgical treatment of musculoskeletal injuries in children. By providing immobilization of the femur, knee, and hip, the DF2® Brace offers a superior alternative to the traditional spica cast for femur fracture fixation in pediatric patients aged 6 months to 5 years.
For decades, spica casts have been considered the standard of care for femur fractures in children. However, the DF2® Brace has emerged as a game-changer in the field of pediatric orthopedics. Extensive research and a multi-center trial have demonstrated that this brace design delivers equivalent outcomes both radiographically and clinically. Moreover, in most cases, it eliminates the need for patients to undergo anesthesia in the operating room.
Joe Hauser, President of Trauma and Deformity Correction at OrthoPediatrics, expressed his enthusiasm for this groundbreaking development, stating, “This is the first product launch for the OrthoPediatrics Specialty Bracing group and will significantly improve the care of kids with femur fractures. The ability to eliminate anesthesia and complications associated with spica casts, all while reducing the overall cost of care, is a significant advancement in pediatric orthopedics for patients, their families, and surgeons.”
OrthoPediatrics Corp., founded in 2006, has established itself as a leader in the field of pediatric orthopedics. With a focus solely on advancing the treatment of orthopedic conditions in children, the company has developed an extensive product offering to cater to this specialized market. Currently, OrthoPediatrics markets 52 surgical systems that serve three major categories within pediatric orthopedics: trauma and deformity, scoliosis, and sports medicine/other procedures. Their global sales organization is dedicated exclusively to pediatric orthopedics, ensuring their products reach patients in over 70 countries worldwide.
The release of the DF2® Brace represents a significant step forward in improving the lives of children with orthopedic conditions. By offering a non-surgical alternative to spica casts, OrthoPediatrics is revolutionizing the treatment of femur fractures in pediatric patients. This innovative brace not only eliminates the need for anesthesia but also reduces complications associated with traditional casts. With a focus on enhancing patient care, OrthoPediatrics continues to lead the way in pediatric orthopedics, providing innovative solutions that benefit patients, their families, and surgeons alike.
For more information about OrthoPediatrics Corp. and their groundbreaking advancements in pediatric orthopedics, please visit their website at www.orthopediatrics.com.